Market Overview

UPDATE: JMP Securities Downgrades Nice-Systems As Risk/Return Trade-Off Is Balanced

Share:

In a report published Tuesday, JMP Securities analyst Greg McDowell downgraded the rating on Nice-Systems Ltd. (ADR) (NASDAQ: NICE) from Market Outperform to Market Perform, and removed the $58.00 price target.

In the report, JMP Securities noted, "We are downgrading NICE Systems to Market Perform from Market Outperform as we feel the risk/return trade-off is balanced at the current valuation, given the ~50% gain in the stock in the last six months (versus NASDAQ up ~11%) and we see a lack of foreseeable catalysts to drive the multiple higher.

"The main positive of this story is that we believe NICE's management team is doing an admirable job: 1) executing on its mission; 2) growing its analytics portfolio; and 3) driving operational excellence in the business. The risk that causes us to move to the sidelines, with the stock trading ~3% above our prior $58 price target, is that we do not expect the company to significantly accelerate growth in 2015, and with shares trading at peak historical forward P/E multiples (19x versus a five-year average of ~15x), we think this is a good time to step to the sidelines.

"We maintain our 2015 non-GAAP EPS estimate of $3.13 (versus consensus of $3.13), and lower our 2016 non-GAAP EPS estimate from $3.76 to $3.56 (versus consensus of $3.48). NICE shares trade at 3x EV/2016 revenue, 6x EV/2016 recurring revenue, and 19x and 17x our 2015 and 2016 EPS estimates, respectively."

Nice-Systems closed on Monday at $59.80.

Latest Ratings for NICE

DateFirmActionFromTo
Jan 2019Morgan StanleyMaintainsEqual-WeightEqual-Weight
Oct 2018WedbushInitiates Coverage OnOutperform
Sep 2018JefferiesMaintainsBuyBuy

View More Analyst Ratings for NICE
View the Latest Analyst Ratings

Posted-In: Greg McDowell JMP SecuritiesAnalyst Color Downgrades Analyst Ratings

 

Related Articles (NICE)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
RCIIJefferiesMaintains22.0
DPLOMorgan StanleyMaintains8.0
QLYSSummit Insights GroupDowngrades0.0
ECACitigroupReinstates0.0
BTXRaymond JamesMaintains5.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Trader Essentials
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Why Intercept Might Be A Better Bet Than Biogen Right Now

ARIAD and Medison Pharma Announce Approval of Iclusig (Ponatinib) in Israel